It has been demonstrated that the cellular defect in Tangier disease is associated with morphological abnormalities in the lysosomal compartment and in the Golgi apparatus of mononuclear phagocytes (MNPs) after lipid loading by exposure to acetylated low density lipoproteins (acetyl-LDLs). On exposure to acetyl-LDL, Tangier MNPs accumulate two unusual types of vacuoles that were not observed in control MNPs. The electron-lucent type I vacuoles are round or ovoid, form aggregates, and are filled with fine flocculent or fibrillar material. Type II vacuoles are filled with more electron-dense material, are larger, and contain scrolls and lamellae with varying degrees of electron opacity. By immunoelectron microscopy both types of vacuoles could be identified as lysosomes. This abnormality of the lysosomal compartment in Tangier MNPs was not observed in Tangier fibroblasts, where the few lysosomes detected were found to be similar to those of controls. Morphological analysis of the Golgi apparatus in Tangier MNPs revealed numerous dilated Golgi cisternae, which were distributed more widely throughout the cell. However, both Tangier MNPs and especially Tangier fibroblasts showed a marked hyperplasia of the Golgi complex. Specific staining of the Golgi apparatus with the fluorescent ceramide analogue iV-[7-(4-nitrobenzo-2-oxa-l,3-diazole)]-6-aminocaproylsphingosine (C 6 -NBD-ceramide) showed that Tangier fibroblasts incorporated significantly higher amounts of C 6 -NBD-ceramide than did control fibroblasts. Moreover, the Tangier fibroblasts that appear generally larger than normal fibroblasts also show significant staining along the cytoskeleton, which may indicate the association of fluorescent ceramide and sphingomyelin to cytoskeletal elements. Phospholipid synthesis and catabolism were studied in Tangier fibroblasts from five patients with the use of tritiated choline as a tracer. A significantly higher incorporation rate was measured for sphingomyelin (176±18% of control) and phosphatidylcholine (144±12% of control). A moderate increase in catabolism was found for sphingomyelin (20 ±8% of control) and phosphatidylcholine (11 ±4% of control). These data are principally in agreement with our former studies of the abnormalities of phospholipid metabolism in Tangier 
Lipoprotein analysis reveals that the serum concentrations of the main apolipoproteins (apos) of HDL (apo A-I and apo A-II) are reduced to levels that are less than 1% of normal for apo A-I 6 -7 and to 5-10% of normal for apo A-II. 8 - 10 However, defects in the synthesis, structure, and processing of apo A-I and apo A-II could not be identified. 11 - 13 Because small intestinal epithelial cells of Tangier disease patients contained normal amounts of apo A-I, it was concluded that the decrease in serum apo A-I was due to a rapid catabolism of HDL in Tangier disease. 1415 Until now the increased catabolism of HDL is best explained by a defect in the interaction of HDL precursors with cells that are critically dependent on HDL-mediated cholesterol efflux. We have studied the interaction of normal HDL with Tangier monocyte/macrophages and have demonstrated that in Tangier disease there is a disorder of "intracellular traffic," whereby HDL precursors that bind to the HDL receptor fail to assemble with cellular lipids and are erroneously directed to lysosomes of the affected cells. 16 In our recent studies of the regulation of cholesterol efflux from macrophages, 17 " 20 we have shown that two major routes exist by which macrophages, in addition to physicochemical exchange, can release excess cholesterol: 1) an HDL receptor-dependent secretion of cholesterol, stimulated by acyl-coenzyme A-cholesterohacyltransferase (ACAT) inhibitors, which induce the formation of "lamellar bodies" originating from lipid droplets. These lamellar bodies are not directly secreted by the cells. However, when HDL is added to the medium, the lamellar bodies transfer their cholesterol to HDL particles and disappear concomitantly with the HDL receptor-mediated cholesterol efflux. 2) an HDL receptor-independent release of cholesterol, stimulated by dihydropyridine calcium antagonists, which induce the formation of membrane-surrounded lamellar bodies originating from lysosomes. These lamellar bodies are released into the surrounding medium by an HDL receptor-independent mechanism that may be promoted by apo A-FV and lecithin cholesterol: acyltransferase (LCAT)-rich HDL particles. Both of these mechanisms obviously involve phospholipid synthesis, as indicated by the formation of lamellar bodies. 1819 The coordinate regulation of cellular lipid metabolism is defective in monocyte/macrophages of patients homozygous for Tangier disease, and we have demonstrated that the cellular defect is associated with significant abnormalities in cellular phospholipid, triglyceride, and cholesteryl ester metabolism. 21 Tangier mononuclear phagocytes (MNPs) express about twofold increased rates of synthesis for phospholipids, about fivefold for triglycerides, and about threefold for cholesteryl esters compared with normal MNPs.
The catabolism of cellular phospholipids as reflected in turnover studies is also enhanced, whereas the catabolic rates for triglycerides and cholesteryl esters are normal, thus leading to the accumulation of a larger pool of labeled triglycerides and cholesteryl esters in Tangier MNPs. The individual phospholipid classes phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, and phosphatidylserine are all similarly affected.
Cholesterol loading leads to a 30% downregulation of phospholipid synthesis in normal cells, but Tangier MNPs show a smaller response. In this article, we present evidence that the defect in cellular lipid metabolism in Tangier monocyte/macrophages is correlated with the appearance of morphological abnormalities in the lysosomal compartment and in the Golgi system. Moreover, we demonstrate that the defect in Tangier disease is also detectable in Tangier fibroblasts, although the morphologically observed changes in fibroblasts are confined to the Golgi cisternae.
Methods

Patients
Monocytes and cutaneous fibroblasts were obtained from five patients homozygous for 
Human Monocyte-Derived Macrophages
White blood cells from normal healthy volunteers and from patients with Tangier disease were collected by leukapheresis in a Hemonetics V 50 cell separator system. Aliquots of 42 ml (containing 2x10" cells//xl) of the cell suspension were mixed with 8 ml 8% dextran T-500 solution in a 50-ml plastic syringe and allowed to settle at room temperature for 40 minutes. The supernatants were pooled and centrifuged at 400g for 10 minutes at 4°C. The cells were resuspended in 15 ml Hanks' buffer (Ca 2+ and Mg 2 * free) containing 0.5% human serum albumin and injected into a Beckman JE-6 elutriator rotor with a standard separation chamber with the pump off, with the rotor speed at 2,040 rpm, and with the temperature at 15°C. This was followed by addition of 60 ml Hanks' buffer/0.5% human serum albumin at a flow rate of 7 ml/min. The first 100-ml fraction was collected at rate of 9 ml/min. Fractions 2-7 (150 ml each) were collected at flow rates of 12, 15, 18, 20, 22 , and 24 ml/min, respectively. After the rotor was stopped, the remaining cells in the separation chamber were collected in another fraction. Aliquots of the fractions were analyzed with a Becton Dickinson FACS-Star to discriminate between granulocytes, monocytes, and lymphocytes. The purest fractions of monocytes were pooled, centrifuged at 200g for 10 minutes, and resuspended in 20 ml phosphate-buffered saline (PBS) containing 0.5% human serum albumin. The cells were cultured for 8 days on 35xlO-mm dishes in a humidified incubator at 37°C with 5% CO 2 at a cell density of about 3x 10 
Lipoproteins
Human low density lipoprotein (LDL, d=1.019-1.063 g/ml) and lipoprotein-deficient serum (LPDS, d>1.23 g/ml) were isolated from serum of individual normolipidemic volunteers by sequential ultracentrifugation in a Beckman L 8-70 ultracentrifuge equipped with either a 50.3 Ti or 70 Ti rotor (Beckman) at 4°C. The lipoprotein fractions were dialyzed against 0.15 mol/1 NaCl and 5 mmol/1 Na 2 EDTA (pH 7.4) at 4°C. All concentrations of lipoproteins are given in terms of their protein content with albumin as a standard.
Chemical Modification of Low Density Lipoproteins and Cholesterol Loading of Cells
LDL was acetylated (acetyl-LDL) by repeated additions of acetic anhydride and was dialyzed against PBS (pH 7.4) at 4°C. 22 The modified LDL showed enhanced mobility on agarose gel electrophoresis at pH 8.6. Cholesterol loading of macrophages was performed by incubating the dishes at 37°C with acetyl-LDL at various time intervals. Protein concentration and the time intervals used are indicated in the figure legends.
Processing for Electron Microscopy
Conventional ultrathin sectioning. At the end of the experiments the cells were fixed directly in the culture dish in diluted Karnovsky fixative 23 (3% glutaraldehyde and 4% paraformaldehyde buffered with 0.1 mol/1 cacodylate, pH 7.4) at 4°C for 30 minutes. The cells were postfixed for 60 minutes with 1% OsO 4 in distilled water and then dehydrated in an ascending ethanol series. The cells were removed from the bottom of the culture dish during the propylene oxide step and pelleted before being embedded in Epon 812. Diamond knives were used to cut ultrathin sections, which were mounted on 200-mesh copper grids covered with or without Formvar support films. Ultrathin sections were poststained with saturated uranyl acetate in distilled water and 1% (wt/vol) lead citrate.
Preparation of protein A-gold complexes. Monodisperse gold sols of 8-and 12-nm-diameter gold particles were prepared by reduction of chloroauric acid with sodium citrate. 24 Binding of protein A to gold particles was performed following the protocol of Roth et al. 25 Aliquots were taken from the preparations, and the stability of the conjugates was tested by addition of 10% NaCl. All preparations were routinely examined by negative staining before use.
Negative staining. Negative staining was performed by placing a Formvar-coated grid for 1-5 minutes on a drop of diluted solution of gold-labeled protein A, which was then transferred to a drop of distilled water for 1 minute and finally to a drop of 2% uranyl acetate (pH 3.5) for 1-5 minutes. 26 The grids were examined in a Philips Model 201 electron microscope operated at 60 kV. Negative staining verified that a clear halo of protein A surrounded the gold particles.
Postembedding immunocytochemical labeling for cathepsin D. For postembedding immunocytochemical labeling, the cells were fixed in a mixture of 4% paraformaldehyde and 1% glutaraldehyde in 0.1 mol/1 cacodylate buffer (pH 7.4) and PBS (pH 7.4), dehydrated in an ascending series of dimethylformamide, and embedded in Lowicryl K 4 M as described previously. 27 The osmification step was omitted. All subsequent treatments of the grids were performed at room temperature. Immunocytochemical labeling was performed by floating the grids serially, section side down, on 10-^.1 droplets placed on wax sheets as follows: 1) Pretreatment to block nonspecific binding sites and to quench aldehydes present at the section surface was performed with 0.2% glycine in PBS (pH 7.4) and/or 1% bovine serum albumin (BSA) in PBS (pH 7.4) for 15 minutes followed by two 5-minute washes in PBS. 2) After this pretreatment the grids were placed on drops with an appropriate dilution of the primary antibody (50 iiglroX) directed against cathepsin D in PBS (pH 7.4) containing 1% BSA, followed by three 5-minute washes in PBS. Polyclonal rabbit anti-human cathepsin D affinitypurified antibodies were prepared and characterized by the group of von Figura and Hasilik and stained with aqueous saturated uranyl acetate and 1% (wt/vol) lead citrate before examination in a Philips Model 201 electron microscope operated at 60 kV. 5) The specificity of immunostaining was controlled by treating the grids as described above, but the primary antibody was omitted.
Determination of Phospholipid Synthesis and Catabolism
Phospholipid synthesis was determined in intact fibroblasts by [ 3 H]choline incorporation by a procedure described earlier. 3031 Incorporation studies were performed after a 16-hour incubation of the cells with either 15% fetal calf serum (FCS) or 15% LPDS. Cells were then pulsed for various time intervals (30-240 minutes) with [ 3 H]choline (5 /LtCi/ml). At the end of the incubation period the cells were washed three times with 1 ml Dulbecco's modified Eagle medium (DMEM) and once with PBS. Delipidation and analysis of radiolabeled phospholipids was performed as described earlier.
2 '-32 Phospholipid catabolism was measured in the same way as phospholipid synthesis, with the exceptions that after a 90-minute pulse period the label was exchanged by normal medium containing either 15% FCS or 15% LPDS and the cells were incubated for another 2 hours. The disappearance of the radiolabel in presynthesized phospholipids was then measured and defined as catabolism.
Staining of the Golgi Apparatus With N-[7-(4-nitrobenzo-2-oxa-l,3-diazole)]-6-aminocaproylsphingosine (C 6 -NBD-Ceramide)
The fluorescent dye Q-NBD-ceramide is a vital stain that is specifically incorporated into the Golgi apparatus of living cells. 3334 Lipid vesicles were formed by ethanol injection of Q-NBD-ceramide and dioleoylphosphatidylcholine in a molar ratio of 20:80 into 10 mM A^-[2-hydroxyethyl]piperazine-Af'-[2-ethanesulfonic acid] (HEPES)-buffered Ca 2+ , Mg 2+ Puck's saline and subsequent dialysis at 4°C overnight against this buffer. 34 The vesicle preparation was diluted with 18 mM DMEM to a final concentration of 5-10 nmol/ml Q-NBD-ceramide.
Control and Tangier fibroblasts were cultured on 35-mm dishes with DMEM containing either 15% FCS or 15% LPDS. Cells were then washed free of culture medium and incubated with liposomes (for 30 minutes at 2°C) to promote Q-NBD-ceramide uptake by net transfer. 35 The cells were then washed, incubated in 18 mM DMEM for 30 minutes at 37°C, and observed in a Bio-Rad confocal laser microscope (excitation at 488 nm, emission >575 nm). Faint background NBD fluorescence against the bright fluorescence of the Golgi apparatus is due to membrane fluorescence that increased with incubation time, reflecting the metabolism of Q-NBD-ceramide to fluorescent sphingomyelin and cerebroside and their translocation to the plasma membrane. 3436 
Other Methods
The protein content of the lipoprotein fractions and cells was determined by the method of Lowry et al 37 with the use of BSA as a standard.
Results
Incubation With Acetylated Low Density Lipoprotein
Under normal culture conditions, that is, without any further treatment, the ultrastructure of control and Tangier MNPs appeared broadly similar. When either cell type was exposed to acetyl-LDL for 24 hours at 37°C, marked changes in ultrastructure occurred. Control MNPs accumulated abundant small membrane-free lipid droplets, which occupied a substantial portion of the cytoplasm (Figure 1) . In Tangier MNPs, fewer cytoplasmic lipid droplets were observed ( Figure 2, upper panel) . Instead, the cytoplasm was filled with two types of vacuoles, referred to as type I and type II vacuoles, which were not observed in control MNPs. Type I vacuoles were usually rounded or ovoid, were often distributed in aggregates, and generally appeared homogeneously pale at low magnification. At high magnification these vacuoles showed a substructure comprising fine flocculent or fibrillar material in an electron-lucent matrix ( Figure 2 , lower left panel). Type II vacuoles contained more electron-dense material. They were generally larger than type I vacuoles, and their substructure consisted of scrolls and lamellae with varying degrees of electron opacity (Figure 2 , lower right panel). A juxtaposition of or perhaps a connection between these two types of vacuoles was sometimes observed. It is interesting to note here that similar translucent lysosomal organelles, which may resemble the type I vacuoles described in this report, were recently described by Schmitz et al 38 for foam cell macrophages in spleen punctures from Tangier patients.
Lipid analysis of the lysosomal fraction of Tangier MNPs isolated by density gradient centrifugation revealed that these organelles contain more (30-50%) esterified and unesterified cholesterol, triglycerides, phosphatidylcholine, and sphingomyelin than do control MNPs (data not shown). In addition, lysyphosphatidylcholine, diacylglycerol, ceramide, and phosphatidic acid contents were also found to be enhanced.
Lysosomal Identity of Vacuoles in Tangier Mononuclear Phagocytes
To determine whether the two vacuole types in Tangier cells were forms of lysosomes, immunogold cytochemistry was performed to localize the lysosomal marker enzyme cathepsin D. This was done by postembedding immunoelectron microscopy with monospecific antibodies to cathepsin D. Both type I and type II vacuoles were found to be intensively and specifically labeled with this technique (Figure 3) . The staining pattern revealed a strong heterogeneity in the morphology of the lysosomal compartment after acetyl-LDL treatment within Tangier MNPs. Contrast between and delineation of type I and type II vacuole substructures were less than optimal because the sections were minimally stained with uranyl acetate and lead citrate to better visualize the gold particles. Although gold particles were abundant over both types of vacuoles, they appeared to be most concentrated over the more electron-dense regions of type II vacuoles. Gold particles were rarely seen over the other organelles such as the nuclei, mitochondria, cisternae of the endoplasmic reticulum, or the cytoplasm. The Golgi apparatus was always completely devoid of label (Figure 3 inset) . Omission of the primary antibody and staining with protein A-gold alone produced no labeling, demonstrating the specificity of staining.
In Tangier MNPs the lysosomal compartment was much larger than that of control MNPs (Figure 4) . Individual lysosomes in Tangier MNPs were more intensively stained with the cathepsin D antibody. As shown in control MNPs (Figure 4) , small pale lysosomes were distributed among the abundant lipid droplets. Gold label within these lysosomes was mainly confined to electron-dense fibrillar material within their interiors. The lipid droplets and the Golgi apparatus were completely free of label, as were the other cellular organelles.
The Golgi Apparatus in Control and Tangier Mononuclear Phagocytes and Fibroblasts
It was apparent from analysis of standard thin sections that control and Tangier MNPs differed in the extent of the Golgi apparatus ( Figure 5 ). In control MNPs, the Golgi apparatus was confined to the nuclear poles and exhibited small cisternae (Figure 5, left panel) . In Tangier MNPs ( Figure 5 , right panel) in contrast, more numerous dilated Golgi cisternae were observed, and these were distributed more widely throughout the cell. When control and Tangier fibroblasts were compared (Figure 6 ), a corresponding but even more pronounced difference in the Golgi apparatus was observed. As shown in Figure  6 , left panel, control fibroblasts have a small Golgi apparatus, typically comprising three to five regularly stacked cisternae, which because of their small size are not revealed in the majority of sections through the cell. In Tangier fibroblasts ( Figure 6 , right panel) however, marked hyperplasia of the Golgi apparatus is apparent, making it easily detectable in all sections. Typically, five to seven cisternae are present per stack. Semiquantitative analysis of the sections confirmed the magnitude of this difference.
Lysosomes of Control and Tangier Fibroblasts
When the lysosomal compartments of control (Figure 7 , left panel) and Tangier ( Figure 7 , right panel) fibroblasts were localized with cathepsin D, in both cases only a few lysosomes were labeled, and those that were positive were only weakly labeled.
Phospholipid Synthesis and Catabolism in Control and Tangier Fibroblasts
The rate of phospholipid biosynthesis was studied in cultured control fibroblasts (n=5) and fibro.blasts When phospholipid catabolism was analyzed, there was only a modestly higher level of sphingomyelin (20±8%, n=3) and phosphatidylcholine (11±4%, «=3) in Tangier fibroblasts ( Figure 8 ) compared with our former observations in Tangier MNPs. 21 Moreover, the relation of the phosphatidylcholine/sphingomyelin increase between MNPs and fibroblasts is inverted (in MNPs, increase in phosphatidylcholine > sphingomyelin; in fibroblasts, increase in sphingomyelin > phosphatidylcholine).
Staining of the Golgi Apparatus in Tangier and Control Fibroblasts With Cg-NBD-Ceramide
Sphingomyelin synthesis from its precursor ceramide preferentially takes place in the Golgi complex, and it has been shown that the ceramide analogue C 6 -NBD-ceramide is a specific Golgi marker that is
•4 FIGURE 3. Transmission electron photomicrographs showing localization of cathepsin D in Tangier mononuclear phagocytes cultivated in the presence of 70 \xglml acetylated low density lipoprotein for 24 hours at 37"C. Cathepsin D was revealed by postembedding immunoelectron microscopy with monospecific antibodies to cathepsin D and the protein A-gold (8 nm) technique. Both type I and type II vacuoles were found to be intensively and specifically labeled. Although gold particles were abundant over both types of vacuoles, they appeared to be most concentrated over the more electron-dense regions of type II vacuoles. Gold particles were rarely seen over the other organdies such as the nuclei, mitochondria, cisternae of the endoplasmic reticulum, or the cytoplasm. The Golgi apparatus was always completely devoid of the gold label (inset). x46,000; inset, x60,000.
incorporated in vital cells into fluorescent sphingomyelin and cerebroside. 33 We have analyzed the fluorescence distribution of Q-NBD-ceramide in Tangier fibroblasts and compared the results with those for control cells. As is obvious from Figure 9 , Tangier fibroblasts ( Figure 9 , right panel) incorporate significantly higher amounts of Q-NBD-ceramide into their Golgi complex than do control fibroblasts ( Figure 9, left panel) . In addition, there is more "reticular fluorescence" visible in Tangier fibroblasts compared with that of controls, and the Tangier cells are generally larger. The retic- of the Golgi apparatus. It was also observed that with increasing time of incubation the fluorescence of the plasma membrane increased, but the rate of increase was less in Tangier fibroblasts than in normal cells. This indicates that Tangier fibroblasts accumulate more fluorescent ceramide within the Golgi apparatus and also associate it to cytoskeletal elements but translocate less fluorescent sphingomyelin to the plasma membrane. This is in agreement with the results shown in Figure 8 , in which a radiotracer was used to estimate phospholipid synthesis and catabolism. 3 We 16 have recently shown that cholesterol efflux from Tangier MNPs may be impaired because HDL precursors that bind to the HDL receptor fail to assemble correctly with intracellular cholesterol and phospholipids and are then erroneously directed to lysosomes in affected cells.
Tangier disease therefore appears to be a disorder of intracellular traffic. Furthermore, when the cells are loaded with lipid by incubation with acetyl-LDL, there are significant differences between normal and Tangier MNPs. When monocyte-derived macrophages are exposed to acetyl-LDL, Tangier cells accumulate more cholesteryl esters than do normal cells. 21 In the studies reported here, we have demonstrated by morphological analysis that Tangier MNPs also differ markedly from control MNPs after cholesterol loading. As reported previously, 18 -39 - 41 internalized cholesterol in control MNPs is first directed to lysosomes and then stored in lipid droplets, and our present results confirm the accumulation of lipid droplets under these conditions. In Tangier MNPs, in contrast, lipid droplet accumulation does not occur to the same extent. Instead, a massive accumulation of two unusual forms of vacuoles is seen. This result demonstrates that a major defect in the intracellular processing of internalized cholesterol can be discerned ultrastructurally in Tangier MNPs. To understand the nature of this defect it was important to establish the identity of the unusual vacuoles in the cholesterol-loaded Tangier MNPs. Our immunocytochemical experiments were directed to this end. These experiments demonstrated that both forms of vacuoles represent lysosomes. Whether the two distinct morphological forms of the vacuoles reflect different stages in maturation of a single type of lysosome or are separate types of lysosomes engaged in different types of degradative activity is uncertain. However, the fact that such a marked accumulation of lysosomes is seen indicates that a block in the normal mechanism of transfer from the lysosomal compartment to lipid droplets must exist in Tangier MNPs.
This defect in lysosomal processing underlines our former observations that there is an abnormal cellular processing of HDL precursors in Tangier MNPs   16 that is associated with a dysregulation of cellular lipid metabolism. This leads to an overproduction of triglycerides and esterified cholesterol and to enhanced synthesis and catabolism of phospholipids. 21 Analysis of the lysosomal acid cholesteryl ester hydrolase (ACEH) activity in which cells were exposed for a short time (0-3 hours) to acetyl-LDL showed normal activity for this enzyme in Tangier MNPs, suggesting that lysosomal cholesteryl ester metabolism is not impaired. On the other hand, cytoplasmic cholesteryl ester formation catalyzed by ACAT and hydrolysis catalyzed by neutral cholesteryl ester hydrolase (NCEH) were both enhanced two-to threefold in Tangier MNPs from five patients (H. Robenek and G. Schmitz, unpublished observations). This abnormal cytoplasmic cholesteryl ester metabolism may occur because the free cholesterol delivered from lysosomes is not removed by the HDL pathway and thus enhanced synthesis is stimulated, which is followed by enhanced catabolism. Accompanying the massive production of lysosomes in Tangier MNPs is a marked hyperplasia of the Golgi apparatus. As well as becoming widely distributed throughout the cell, the Golgi of Tangier MNPs differs in appearance from those of control MNPs. Specifically, the trans cisternae of the Golgi in Tangier MNPs are markedly dilated. One possible explanation for these changes is that under conditions of a blocked cholesterol transfer, an extra demand is placed on the Golgi for production of lysosomal enzymes. A second and more likely possibility is that these morphological changes reflect a reactive overproduction of sphingomyelin and phospholipids. We have shown elsewhere 21 that increased synthesis of these lipids occurs in Tangier MNPs. The phospholipid metabolism observed in these studies in fibroblasts from Tangier patients is somewhat different from that in Tangier MNPs. Thus, the overall rate of phospholipid synthe- sis is lower in Tangier fibroblasts than in the basal state ( Figure 8 ). In addition, when cells are stimulated by cholesterol loading, the fibroblasts show a different pattern from MNPs; in MNPs the increased synthesis of phosphatidylcholine is greater than sphingomyelin, while in fibroblasts the opposite is observed. Furthermore, whereas acetyl-LDL enhances phospholipid catabolism in Tangier MNPs, there is no change in fibroblasts. The origin of these observations requires further elucidation but may reflect differences in lysosomal regulation between the two cell types.
Studies with fluorescent C 6 -NBD-ceramide in fibroblasts ( Figure 9 ) have provided evidence for intracellular synthesis of sphingomyelin and translocation via the Golgi apparatus to the cell surface and for a major degradative role of the lysosome.
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The dysregulation of phospholipid metabolism in Tangier fibroblasts and MNPs from Tangier patients 21 and the significantly higher accumulation of C 6 -NBD-ceramide in the Tangier Golgi complex underline the electron microscopic data, which show an increase in Golgi elements and an abnormal dilatation of the trans-Golgi cisternae in Tangier cells. In addition, these data show for the first time that the defect in Tangier disease is also present in fibroblasts, which opens new possibilities for continuous research of cultured cells instead of collection of monocytes by leukapheresis only two to three times a year from the few Tangier patients.
Our results indicate that the Golgi apparatus of Tangier fibroblasts shows the same characteristic changes observed in Tangier MNPs. Tangier fibroblasts do not, however, show alterations in the lysosomal compartment seen in the MNPs, presumably because of the fundamental differences in the way macrophages and fibroblasts metabolize cholesterol. This may reflect the principal functional differences of these two cell types as a phagocytosing cell type versus a structural constituent.
The abnormal phospholipid metabolism and the morphological abnormalities in Tangier cells during cholesterol loading are a reflection of the metabolic defect within the cell. There are a number of possible causes: 1) abnormalities in signal transduction between the plasma membrane and the enzyme systems located in the different cellular organelles; 2) a defect in the translocation of cellular lipids from and to the plasma membrane; and 3) a defect in the structure of an enzyme, receptor, or transport protein that is involved in cellular lipid metabolism.
There is some evidence from our current work that suggests that signal transduction may be disturbed because Tangier MNPs, when challenged with HDL, show abnormal protein phosphorylation. On the other hand, the fact that there is an enhanced binding, uptake, and degradation of HDL in Tangier MNPs 14 -16 suggests that lipid translocation by HDL is impaired. This could lead to the observed defect in phospholipid synthesis and turnover. Further evidence for a general abnormality of phospholipid metabolism in Tangier patients comes from the observation that homozygotes for the disease have a significant reduction in plasma total phospholipids and a decrease in the sphingomyelin to phosphatidylcholine ratio. 45 The third hypothesis, that the abnormal phospholipid synthesis and turnover in Tangier MNPs could be related to a functional defect of a key enzyme, carrier protein, or receptor such as the HDL receptor itself, can be surmised by analogy with other inherited disorders of metabolism in which the primary defect has an indirect influence on another region; for example, in lysosomal acid lipase deficiency there is an impaired release of cholesterol from lysosomes, 43 while in familial hypercholesterolemia defects in the LDL receptor cause a secondary increase in hydroxymethylglutaryl-coenzyme A reductase activity. 44 There is as yet, however, no evidence to point to the primary defect in Tangier disease.
Recently, in type C Niemann-Pick disease a massive storage of cholesterol in lysosomes due to a deficient translocation of exogeneous cholesterol from lysosomes to other intracellular sites 45 - 46 as well as a premature cholesterol enrichment of the Golgi complex due to disruptions of the cholesterol transport pathway at the Golgi has been described. 47 Both defects may in part be responsible for the deficiency in cholesterol utilization in type C Niemann-Pick disease. Moreover, when these data are compared with our findings in Tangier disease, striking similarities are obvious, suggesting that Tangier disease belongs to the same group of disorders affecting the translocation of cellular lipids.
However as shown in Figure 10 , there are some principle differences in the cellular abnormalities between Tangier disease (panel B) and type C Niemann-Pick disease (panel C). In type C NiemannPick disease an enlargement of the Golgi complex with a normal morphology of the Golgi cisternae has been described, and in addition, numerous sphingomyelin and cholesterol-containing lamellar bodies are detectable in the trans-Golgi region. 4647 In Tangier disease by contrast, the enlargement of the Golgi complex is associated with morphological abnormalities of the Golgi cisternae, resulting in the accumulation of multiple translucent lipid inclusions but no accumulation of lamellar bodies. Another difference is related to the activities of cholesterol synthesis (hydroxymethylglutaryl-coenzyme A reductase) and cytoplasmic cholesterol esterification (ACAT). Type C Niemann-Pick disease is associated with a processing defect of lysosome-derived cholesterol, which leads to diminished ACAT activity and an enhanced rate of cholesterol synthesis. 48 - 50 In Tangier disease however, there is a low rate of cholesterol synthesis, while ACAT activity is found to be enhanced 3 in the affected cell types (e.g., macrophages and Schwann cells). If one assumes that in normal cells ( Figure  10A ) cholesterol-and phospholipid-rich lamellar bodies are regularly secreted from the trans-Golgi network and are transported via the vesicular trans- port system to the cell surface, it may be speculated that the defect in Tangier disease is associated with a failure to release certain lipids from the trans Golgi ( Figure 10B ). On the other hand, the defect in type C Niemann-Pick disease is associated with a post-Golgi accumulation of lamellar bodies, which might be due to a defect in the transport machinery between the trans Golgi and the cell membrane ( Figure IOC ).
In conclusion, in Tangier disease the cellular defect is associated with a dysregulation of cellular lipid metabolism, leading to an overproduction of triglycerides and esterified cholesterol and to an enhanced synthesis and intracellular catabolism of phospholipids. 21 Tangier macrophages fail to respond normally to HDL interaction 16 with a coordinated regulation of phospholipid, triglyceride, and cholesteryl ester metabolism and thus finally accumulate cholesteryl esters in the affected cells. Moreover, these biochemical abnormalities are associated with morphological abnormalities, which strongly indicate that the translocation disorder in Tangier disease affects the Golgi apparatus and the normal processing of lysosomes.
